What is NDC 68382-720?

68382-720 is the product NDC for budesonide, Budesonide 3 mg/1 capsule, coated pellets, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 6 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for budesonide?

41 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

budesonide NDC 68382-720 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-720Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0720Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68382-720-01	6838207200168382072001	100 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-01)Marketed from Jun 8, 2017
68382-720-05	6838207200568382072005	500 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-05)Marketed from Jun 8, 2017
68382-720-06	6838207200668382072006	30 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-06)Marketed from Jun 8, 2017
68382-720-10	6838207201068382072010	1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-10)Marketed from Jun 8, 2017
68382-720-16	6838207201668382072016	90 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-720-16)Marketed from Jun 8, 2017
68382-720-77	6838207207768382072077	10 BLISTER PACK in 1 CARTON (68382-720-77) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (68382-720-30)Marketed from Jun 8, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): budesonide
Generic name (nonproprietary): budesonide
Active ingredients: Budesonide — 3 mg/1
Dosage form: Capsule, Coated pellets
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 68382
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206134
Marketing start: Jun 8, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 68382-720_08f8aa4f-4543-46d3-91f7-ae943f455648SPL ID 08f8aa4f-4543-46d3-91f7-ae943f455648SPL set ID 29863154-5f98-410e-9bf3-0f08b551edefRxCUI 1244214UNII Q3OKS62Q6XUPC 0368382720016
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382072001 followed by a unit qualifier and the quantity

Package 68382-0720-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 12, 2025.

Indications (excerpt from the label)

Budesonide delayed-release capsules are corticosteroid indicated for: Treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon, in patients 8 years and older. ( 1.1 ) Maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months in adults. ( 1.2 ) 1.1 Treatment of Mild to Moderate Active Crohn’s Disease Budesonide delayed-release capsules are indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of age and older. 1.2 Maintenance of Clinical Remission of Mild to Moderate Crohn’s Disease Budesoni…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68382-720

What is NDC 68382-720?: 68382-720 is the product NDC for budesonide, Budesonide 3 mg/1 capsule, coated pellets, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 6 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: budesonide.
What is the active ingredient?: Budesonide.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for budesonide?: 41 other product NDCs are listed under this name. See all budesonide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other budesonide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Budesonide	Budesonide .25 mg/2mL	SuspensionRespiratory (Inhalation)	American Health Packaging	60687-889	60687-0889-83
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	REMEDYREPACK INC.	70518-4613	70518-4613-00
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Rugby Laboratories	0536-1456	00536-1456-84
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	Walgreens	0363-0048	00363-0048-01
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	49035-703	49035-0703-01
Budesonide	Budesonide 32 ug/1	Spray, MeteredNasal	CVS Pharmacy	69842-001	69842-0001-01
Budesonide	Budesonide 3 mg/1	Capsule, Delayed releaseOral	Amneal Pharmaceuticals of New York LLC	53746-778	53746-0778-10
Budesonide	Budesonide .25 mg/2mL	InhalantRespiratory (Inhalation)	Rising Pharma Holdings, Inc.	64980-638	64980-0638-03
Budesonide	Budesonide .5 mg/2mL	InhalantRespiratory (Inhalation)	Rising Pharma Holdings, Inc.	64980-639	64980-0639-03
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7313	00904-7313-10

All 42 budesonide NDCs

Other NDCs under ANDA 206134

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206134
Product	Strength	Form · route	Labeler	Product NDC
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7313
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	Northstar Rx LLC.	16714-829
Budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	American Health Packaging	60687-596
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	REMEDYREPACK INC.	70518-4613
budesonide	Budesonide 3 mg/1	Capsule, Coated pelletsOral	Zydus Lifesciences Limited	70771-1075